Search

everythinglearnresearchcommunity

for

Search:↓

The paper suggests that hair loss might be caused by skull growth, not just DHT's effect on hair follicles, and calls for more research.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

DHT, a testosterone byproduct, causes male pattern baldness.

Long-term finasteride use doesn't change bone density or metabolism.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Pregnancy reduces anxiety in rats, but finasteride reverses this effect.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Finasteride does not prevent bladder cancer.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Hormone therapy for trans individuals is effective and generally safe in the short term.